Abstract

12 - Ritonavir, a potent inhibitor of CYP3A4, enhances the anticancer effects of panobinostat in bladder cancer cells

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
CircMYLK promotes the growth, migration, invasion, and survival of bladder cancer cells by upregulating CCND3 level via competitively binding to miR‐34a
Wenxin Ye ... Tiejun Liang
Drug Development Research | VOL. 82
Wenxin Ye, et. al.Wenxin Ye ... Tiejun Liang
30 May 2021
Opposite regulation of epithelial-to-mesenchymal transition and cell invasiveness by periostin between prostate and bladder cancer cells
Hirokazu Inoue
International Journal of Oncology | VOL. 38
Hirokazu InoueHirokazu Inoue
05 Apr 2011
A first-in-class TIMM44 blocker inhibits bladder cancer cell growth
Li Zuo ... Lei Zhang
Cell Death & Disease | VOL. 15
Li Zuo, et. al.Li Zuo ... Lei Zhang
11 Mar 2024
Synthesis of Furanocoumarin, Benzofuran and Coumarin Derivatives Possessing an Inhibitory Effect on Human CYP, and Elucidation of the Inhibitory Mechanism.
Yuki Yamaguchi
Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan | VOL. 137
Yuki YamaguchiYuki Yamaguchi
01 Oct 2017
View more papers

More From: European Urology Open Science

Paper Title
Journal
Date
Author
Copyright page
-
European Urology Open Science | VOL. 63
--
01 May 2024
Editorial Board
-
European Urology Open Science | VOL. 63
--
01 May 2024
Contents
-
European Urology Open Science | VOL. 63
--
01 May 2024
Fatigue in Prostate Cancer: A Roundtable Discussion and Thematic Literature Review
Louisa Fleure ... Esther Robijn
European Urology Open Science | VOL. 63
Louisa Fleure, et. al.Louisa Fleure ... Esther Robijn
04 Apr 2024
View more papers